Bottom line
How much do FHLC and HGHAX overlap?
72% of their top holdings overlap by weight. 19 securities appear in both funds' top 25, making up 63.1% of FHLC's assets and 63.0% of HGHAX's. They are largely the same portfolio — owning both adds little diversification.
FHLC holds far more positions (337 vs 80), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and HGHAX have in common
| Holding | % of FHLC | % of HGHAX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 12.03% | 12.03% |
| Johnson & Johnson | 8.93% | 6.75% | 6.75% |
| AbbVie Inc | 6.42% | 4.21% | 4.21% |
| UnitedHealth Group Inc | 5.44% | 4.74% | 4.74% |
| Merck & Co Inc | 4.66% | 6.00% | 4.66% |
| Thermo Fisher Scientific Inc | 3.09% | 1.58% | 1.58% |
| Amgen Inc | 3.00% | 1.39% | 1.39% |
| Abbott Laboratories | 2.66% | 1.82% | 1.82% |
| CVS Health Corp | 1.92% | 2.84% | 1.92% |
| Intuitive Surgical Inc | 1.82% | 2.88% | 1.82% |
| Danaher Corp | 1.80% | 2.57% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.64% | 1.76% |
| Stryker Corp | 1.62% | 1.24% | 1.24% |
| Medtronic PLC | 1.59% | 1.12% | 1.12% |
| Elevance Health Inc | 1.19% | 3.00% | 1.19% |
| Regeneron Pharmaceuticals Inc | 1.15% | 2.02% | 1.15% |
| Boston Scientific Corp | 1.00% | 1.88% | 1.00% |
| HCA Healthcare Inc | 0.91% | 1.88% | 0.91% |
| Cencora Inc | 0.83% | 2.46% | 0.83% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
- Bristol-Myers Squibb Co — 1.93%
- McKesson Corp — 1.52%
- Cigna Group/The — 1.06%
- Cardinal Health Inc — 0.78%
Only in HGHAX
- Edwards Lifesciences Corp — 2.48%
- Agilent Technologies Inc — 1.54%
- Biogen Inc — 1.36%
- Gsk Plc — 1.17%
- Centene Corp — 1.10%
- Dexcom Inc — 1.01%
Asset mix
| Asset type | FHLC | HGHAX |
|---|---|---|
| Stocks | 99.7% | 98.1% |
| Cash & short-term funds | 0.2% | 0.9% |
| Repurchase agreements | — | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | FHLC | HGHAX |
|---|---|---|
| US | 96.5% | 89.6% |
| GB | 0.5% | 2.4% |
| IE | 2.2% | 2.2% |
| NL | 0.1% | 1.5% |
| BE | — | 0.8% |
| DK | — | 0.8% |
| CH | 0.1% | 0.7% |
| CN | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do FHLC and HGHAX overlap?
What stocks do FHLC and HGHAX have in common?
Should I own both FHLC and HGHAX?
Which holds more stocks, FHLC or HGHAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.